Edgewise Therapeutics, Inc., (NASDAQ:EWTX) revealed topline results from the Phase 2 CANYON trial of sevasemten in ...

After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ ...

With this finding, the modern era of interventional immunology emerged ... many of which have potential as therapeutic targets, as is discussed in a Review by Iain McInnes and Georg Schett ...

Edgewise Therapeutics, Inc.(EWTX), a muscle disease biopharmaceutical company, announced Monday positive topline results from the ...

Edgewise Therapeutics (EWTX) announced topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive topline results from the Pha ...

Edgewise Therapeutics’ lead candidate has been shown to reduce levels of a biomarker related to skeletal muscle damage in a ...

This article reviews various interventional therapeutic options for the management of AF, appropriate patient selection and clinical implications.

Aim: To survey the voluntary opinion of parents about consenting for non-therapeutic interventional research in paediatric trauma. Materials and Methods: We approached the parents of children ...

As part of our comprehensive lung program, our board-certified interventional pulmonologists perform advanced diagnostic bronchoscopy, pleural procedures, and therapeutic bronchoscopy. The ...

Under the partnership, Medicover Hospitals will utilise Lupin Digital Health’s advanced Digital Therapeutics (DTx) platform, ...